LPS Down-Regulates Specificity Protein 1 Activity by Activating NF-?B Pathway in Endotoxemic Mice.

ABSTRACT:

Background

Specificity protein (Sp) 1 mediates the transcription of a large number of constitutive genes encoding physiological mediators. NF-?B mediates the expression of hundreds of inducible genes encoding pathological mediators. Crosstalk between Sp1 and NF-?B pathways could be pathophysiologically significant, but has not been studied. This study examined the crosstalk between the two pathways and defined the role of NF-?B signaling in LPS-induced down-regulation of Sp1 activity.

Methods and main findings

Challenge of wild type mice with samonelia enteritidis LPS (10 mg/kg, i.p.) down-regulated Sp1 binding activity in lungs in a time-dependent manner, which was concomitantly associated with an increased NF-?B activity. LPS down-regulates Sp1 activity by inducing an LPS inducible Sp1-degrading enzyme (LISPDE) activity, which selectively degrades Sp1 protein, resulting in Sp1 down-regulation. Blockade of NF-?B activation in mice deficient in NF-?B p50 gene (NF-?B-KO) suppressed LISPDE activity, prevented Sp1 protein degradation, and reversed the down-regulation of Sp1 DNA binding activity and eNOS expression (an indicator of Sp1 transactivation activity). Inhibition of LISPDE activity using a selective LISPDE inhibitor mimicked the effects of NF-?B blockade. Pretreatment of LPS-challenged WT mice with a selective LISPDE inhibitor increased nuclear Sp1 protein content, restored Sp1 DNA binding activity and reversed eNOS protein down-regulation in lungs. Enhancing tissue level of Sp1 activity by inhibiting NF-?B-mediated Sp1 down-regulation increased tissue level of IL-10 and decreased tissue level of TNF- ?in the lungs.

Conclusions

NF-?B signaling mediates LPS-induced down-regulation of Sp1 activity. Activation of NF-?B pathway suppresses Sp1 activity and Sp1-mediated anti-inflammatory signals. Conversely, Sp1 signaling counter-regulates NF-?B-mediated inflammatory response. Crosstalk between NF-?B and Sp1 pathways regulates the balance between pro- and anti-inflammatory cytokines.

SUBMITTER: Ye X 

PROVIDER: S-EPMC4478004 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature